Keyword: respiratory medicine

News

Roche's $8 billion InterMune Buy Not a Sign of More Big Deals

19.09.2014 - The decision by Swiss drugmaker Roche in August to buy US biotech company InterMune for $8.3 billion was "exceptional" and not a sign of more ambitious plans for major acquisitions...

Pharma- & Biotech Processing

New Technology for Respiratory Medicines

Prosonix Ltd. - Prosonix, Oxford/UK, has launched UMAX, a new disruptive particle engineering technology to be used in respiratory medicine. The proprietary technology delivers unique crystalline...